CVKD - Cadrenal Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

361.2K

Cash

6.566M

Avg Qtr Burn

-988.5K

Short % of Float

0.41%

Insider Ownership

46.72%

Institutional Own.

10.61%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tecarfarin Details End-Stage Renal Disease , Systemic thromboembolism, Atrial fibrillation	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.